Effective July 1, 2012, physicians who have not met the
qualifications set forth in subsections (1) through (6), below, shall have
successfully completed a pain medicine fellowship that is accredited by the
Accreditation Council for Graduate Medical Education (ACGME) or the American
Osteopathic Association (AOA) or a pain medicine residency that is accredited
by ACGME or the AOA. Prior to July 1, 2012, physicians prescribing or
dispensing controlled substance medications in pain management clinics
registered pursuant to Section
459.0137(1),
F.S., must meet one of the following qualifications:
(1) Board certification by a specialty board
recognized by the American Board of Medical Specialties (ABMS) and holds a
sub-specialty certification in pain medicine; or a Certificate of Added
Qualification in Pain Management by the American Osteopathic
Association;
(2) Board
certification in pain medicine by the American Board of Pain Medicine
(ABPM);
(3) Successful completion
of a pain medicine fellowship that is accredited by the Accreditation Council
for Graduate Medical Education (ACGME) or the American Osteopathic Association
(AOA) or a pain medicine residency that is accredited by the ACGME or the
AOA;
(4)
(a) Successful completion of a residency
program in physical medicine and rehabilitation, anesthesiology, neurology,
neurosurgery, or psychiatry approved by the ACGME or the AOA;
(b) Successful completion of a residency
program in family practice, internal medicine, or orthopedics approved by the
AOA, or
(c) Current Certificate of
Added Qualification approved by the AOA in hospice, palliative medicine or
geriatric medicine.
(5)
Current staff privileges at a Florida-licensed hospital to practice pain
medicine or perform pain medicine procedures;
(6) Three (3) years of documented full-time
practice
, which is defined as an average of 20 hours per week each
year, in pain-management and attendance and successful completion of 40 hours
of in-person, live-participatory AMA Category I or AOA Category IA CME courses
in pain management that address all the following subject areas:
(a) The goals of treating both short term and
ongoing pain treatment;
(b)
Controlled substance prescribing rules, including controlled substances
agreements;
(c) Drug screening or
testing, including usefulness and limitations;
(d) The use of controlled substances in
treating short-term and ongoing pain syndromes, including usefulness and
limitations;
(e) Evidenced-based
non-controlled pharmacological pain treatments;
(f) Evidenced-based non-pharmacological pain
treatments;
(g) A complete pain
medicine history and a physical examination;
(h) Appropriate progress note
keeping;
(i) Comorbidities with
pain disorders, including psychiatric and addictive disorders;
(j) Drug abuse and diversion, and prevention
of same;
(k) Risk management; and,
(l) Medical ethics.
In addition to the CME set forth in subsection (6), above,
physicians must be able to document hospital privileges at a Florida-licensed
hospital; practice under the direct supervision of a physician who is qualified
in subsections (1) through (4), above; or have the practice reviewed by a
Florida-licensed risk manager and document compliance with all recommendations
of the risk management review.
(7) Upon completion of the 40 hours of CME
set forth above, physicians qualifying under subsection (6), above, must also
document the completion of 15 hours of in-person, live participatory AMA
Category I or AOA Category IA CME in pain management for every year the
physician is practicing pain management.